Effects of delta-tocotrienol, resveratrol and vitamin D supplementation mixture on biochemical markers in diabetic patients - Trial SLCTR_2018_019
Access comprehensive clinical trial information for SLCTR_2018_019 through Pure Global AI's free database. This Phase 4 trial is sponsored by Higher Education Commission (HEC) Pakistan and is currently Recruiting. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2018_019
Phase 4
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2018_019
Effects of delta-tocotrienol, resveratrol and vitamin D supplementation mixture on biochemical markers in diabetic patients
Synergistic Effects of delta-Tocotrienol, Resveratrol and Vitamin D Supplementation on Modulation of Biochemical Markers, Cytokines and miRNAs in patients of type 2 diabetes mellitus
Study Focus
Interventional
Sponsor & Location
Higher Education Commission (HEC) Pakistan
Pakistan
Timeline & Enrollment
Phase 4
Jun 28, 2018
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2018_019
Non-Device Trial